Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist


Clinical trials should be considered at any point in a patient's journey with HER2-positive metastatic breast cancer, not just when standard options are exhausted, as they provide early access to promising therapies, novel combinations, and cutting-edge care.

Related Videos
Sue Friedman in an interview with CURE
Catrina Crutcher in an interview with CURE
Related Content